Hydrogen-Bonded Oligo(p-phenylene Vinylene)s
J. Am. Chem. Soc., Vol. 123, No. 3, 2001 415
the reaction vessel was evacuated to remove the water, which was
formed during the reaction. After 6 h the excess of aniline was removed
in vacuo. Recrystallization from a chloroform/methanol/ethanol mixture
afforded 3.18 g (95%) of the desired compound as a white solid: 1H
NMR (CDCl3) δ 0.90 (t, 9H, CH3), 1.63-1.15 (m, 54H, CH2), 1.94-
1.75 (m, 6H, CH2CH2O), 4.18-4.00 (m, 6H, CH2O), 7.13 (s, 2H, ArH),
(m, 4H, OCH2CH(CH3)CH2CH3), 2.00 (m, 6H, OCH2CH2(CH2)9CH3),
3.95-4.06 (m, 14H, OCH2), 6.75 (s, 2H, ArH), 7.06 (d, J ) 16.4 Hz,
1H, ArCHdCH), 7.1-7.2 (m, 6H, ArCHdCH, ArH), 7.4 (d, J ) 16.4
Hz, 1H, ArCHdCH), 7.5-7.6 (m, 6H, ArCHdCH, ArH); 13C NMR
(100 MHz, CDCl3) δ 153.53, 151.96, 151.42, 151.17, 142.90, 138.46,
133.48, 132.66, 129.14, 128.97, 127.57, 127.40, 127.34, 126.93, 126.73,
125.54, 123.61, 122.70, 122.51, 119.37, 111.38, 110.60, 110.37, 110.11,
109.65, 105.35, 74.71, 74.58, 74.42, 74.15, 73.77, 69.32, 35.44, 35.43,
35.37, 35.22, 34.92, 32.21, 31.86, 30.64, 30.04, 30.03, 30.00, 29.95,
29.73, 29.69, 29.66, 29.32, 27.17, 26.68, 26.66, 26.63, 26.42, 25.52,
22.97, 22.92, 18.97, 17.11, 17.08, 17.02, 14.35, 11.78, 11.74, 11.66,
11.62; IR (UATR) υ (cm-1) 2957, 2920, 2852, 2224, 1590, 1505, 1467,
1423, 1391, 1339, 1246, 1203, 1118, 1043, 1009, 966, 851, 821, 721;
MALDI-TOF MS (MW ) 1306.02) m/z 1306.22 [M]+.
7.28-7.18 (m, 3H, ArH), 7.40 (t, 2H, ArH), 8.33 (s, 1H, CHdN); 13
C
NMR (CDCl3) δ 14.23, 22.81, 26.22, 29.49, 29.52, 29.72, 29.76, 29.82,
29.87, 30.47, 32.05, 69.27, 73.63, 107.16, 120.94, 125.77, 129.19,
131.39, 141.31, 152.32, 153.52, 160.31; IR (UATR) υ (cm-1) 2954,
2917, 2872, 2849, 1624, 1579, 1506, 1473, 1463, 1436, 1390, 1373,
1333, 1229, 1154, 1116, 991, 971, 820, 768, 719, 696. Anal. Calcd for
C49H83NO3: C, 80.16; H, 11.39; N, 1.91. Found: C, 80.05; H, 11.29;
N, 1.82.
(E,E)-4-{4-(3,4,5-Tridodecyloxystyryl)-2,5-bis[(S)-2-methylbutoxy]-
styryl}-2,5-bis[(S)-2-methylbutoxy]benzaldehyde (1). (E)-4-{4-Meth-
yl-2,5-bis[(S)-2-methylbutoxy]styryl}-2,5-bis[(S)-2 methylbutoxy]ben-
zaldehyde dimethyl acetal (4.80 g, 7.83 mmol) and (E)-N-Phenyl-3,4,5-
tridodecyloxybenzaldimine (5.75 g, 7.83 mmol) were dissolved in 10
mL of anhydrous DMF. KtBuO (3.18 g, 28.4 mmol) was added to the
solution, and the reaction mixture was heated to 80 °C and stirred for
1 h under an argon atmosphere. The reaction mixture was cooled to
room temperature and poured onto a mixture of 250 g of crushed ice
and 85 mL of 6 N HCl. The mixture was extracted three times with
100 mL of dichloromethane. The combined organic fractions were
washed with water and dried over MgSO4. After evaporation of the
solvent the crude product was purified by column chromatography
(silica gel, pentane/CH2Cl2 1:1) to afford 8.53 g (90%) of aldehyde
compound 1 as an orange solid: 1H NMR (CDCl3) δ 1.18-0.90 (m,
33H, CH2, CH3), 1.89-1.18 (m, 68H, CH, CH2), 2.05-1.90 (m, 4H,
CH), 4.10-3.80 (m, 14H, OCH2), 6.77 (s, 2H, ArH), 7.08 (d, 1H, CHd
CH), 7.13 (s, 1H, ArH), 7.19 (s, 1H, ArH), 7.25 (s, 1H, ArH), 7.34 (s,
1H, ArH), 7.41 (d, 1H, CHdCH), 7.53 (d, 1H, CHdCH), 7.66 (d, 1H,
CHdCH), 10.48 (s, 1H, ArCHdO); 13C NMR (CDCl3) δ 11.75, 11.91,
11.93, 14.55, 11.98, 17.05, 17.18, 17.21, 23.12, 26.56, 26.78, 29.79,
29.82, 29.85, 30.04, 30.08, 30.13, 30.16, 30.18, 30.77, 32.34, 32.36,
35.25,35.31 35.47, 35.53, 69.40, 73.83, 73.97, 74.19, 74.48, 74.56,
105.37, 109.77, 110.40, 110.49, 122.06, 122.50, 124.19, 126.52, 126.61,
127.98, 129.30, 133.24, 135.29, 138.44, 150.74, 151.20, 151.52, 153.37,
156.49, 188.93; IR (UATR) υ (cm-1) 2957, 2922, 2853, 2676, 1593,
1501, 1465, 1422, 1386, 1333, 1242, 1201, 1116, 1041, 965, 852, 723;
MALDI-TOF MS (MW ) 1206.98) m/z 1206.75 [M]+.
Diethyl(4-cyanobenzyl) Phosphonate. A mixture of triethyl phos-
phite (2.54 g, 15.30 mmol) and 4-cyanobenzyl bromide (2.00 g, 10.20
mmol) was stirred at 160 °C for 2 h. During this time ethyl bromide
was distilled from the reaction mixture. Subsequently the mixture was
cooled to 70 °C and the excess of triethyl phosphite was distilled under
reduced pressure. The product, diethyl(4-cyanobenzyl) phosphonate,
was used without further purification: 1H NMR (400 MHz, CDCl3) δ
1.19 (t, 6H, CH3), 3.14 (d, 2H, CH2), 3.98 (dt, 4H, CH2), 7.37 (dd, 2H,
ArH), 7.55 (dd, 2H, ArH); 13C NMR (100 MHz, CDCl3) δ 16.07 (d),
33.78 (d), 62.17 (d), 110.55 (d), 118.43 (d), 127.68 (d), 131.19 (d),
137.34 (d); IR (UATR) υ (cm-1) 2984, 2909, 2227, 1607, 1506, 1479,
1444, 1417, 1392, 1244, 1048, 1018, 958, 857, 824, 780; GC-MS (MW
) 253) m/z 253 [M]+.
2,4-Diamino-6-[(E,E,E)-4- 4-{4-(3,4,5-trisdodecyloxystyryl)-2,5-
bis[(S)-2-methylbutoxy]styryl}-2,5-bis[(S)-2-methylbutoxy]styryl ]-
phenyl-s-triazine (3). In a round-bottom flask 1.97 g (1.51 mmol) of
2 and 0.13 g (1.54 mmol) of Dicyandiamide were dissolved in 20 mL
of 2-methoxyethanol. After adding 0.20 g (3.56 mmol) of KOH, the
solution was stirred for 8 h. Purification was achieved with column
chromatography (silica gel, EtOH/CH2Cl2 2:98). After precipitation in
1
methanol pure 3 (1.55 g, 74%) was obtained. H NMR (400 MHz,
CDCl3) δ 0.95-1.15 (m, 9H, OCH2CH2(CH2)9CH3, 12H, OCH2CH-
(CH3)CH2CH3, 12H, OCH2CH(CH3)CH2CH3), 1.3 (m, 54H, OCH2CH2-
(CH2)9CH3), 1.5-1.7 (m, 8H, OCH2CH(CH3)CH2CH3), 1.9 (m, 4H,
OCH2CH(CH3)CH2CH3), 2.00 (m, 6H, OCH2CH2(CH2)9CH3), 3.95-
4.06 (m, 14H, OCH2), 6.75 (s, 2H, ArH), 7.03 (d, J ) 16.4 Hz, 1H,
ArCHdCH), 7.1-7.2 (m, 6H, ArCHdCH, ArH), 7.4 (d, J ) 16.4 Hz,
1H, ArCHdCHAr), 7.5-7.6 (m, 4H, ArCHdCH, ArH), 8.31 (s, 1H,
ArH), 8.33 (s, 1H, ArH); 13C NMR (100 MHz, CDCl3) δ 11.39, 11.47,
11.51, 14.10, 16.78, 16.85, 22.68, 26.14, 26.40, 29.36, 29.39, 29.44,
29.66, 29.70, 29.75, 30.35, 31.93, 35.00, 35.09, 35.16, 69.12, 73.56,
74.12, 74.22, 74.45, 77.21, 105.14, 109.70, 109.94, 110.47, 110.94,
122.53, 122.94, 125.18, 126.33, 126.89, 127.39, 128.00, 128.10, 128.62,
128.74, 133.24, 135.16, 138.21, 141.43, 151.01, 151.13, 151.18, 151.51,
153.26, 167.66, 172.02; IR (KBr) υ (cm-1) 3170, 3401, 3475 (N-H
stretch); MALDI-TOF MS (MW ) 1391.11) m/z 1390.18 [M]+.
2-Amino-4-butylureido-6-[(E,E,E)-4- 4-{4-(3,4,5-trisdodecyloxy-
styryl)-2,5-bis[(S)-2-methylbutoxy]styryl}-2,5-bis[(S)-2-methylbutoxy]-
styryl ]phenyl-s-triazine} (MOPV). Under an argon atmosphere, 1.35
g (0.97 mmol) of 3 was dissolved in 20 mL of dry pyridine at room
temperature. n-Butylisocyanate (24.1 mg, 0.24 mmol) was added and
the reaction mixture was refluxed for 8 h. After evaporation of the
solvent, the mixture was flushed with toluene to remove the pyridine.
Using column chromatography (2% EtOH in CH2Cl2), pure MOPV
(0.839 g, 58%) was obtained.1H NMR (400 MHz, CDCl3) δ 0.9 (m,
9H, OCH2CH2(CH2)9CH3, 12H, OCH2CH(CH3)CH2CH3, 12H, OCH2-
CH(CH3)CH2CH3), 1.3 (m, 54H, OCH2CH2(CH2)9CH3), 1.5-1.7 (m,
8H, OCH2CH(CH3)CH2CH3, 7H, NCH2(CH2)2CH3), 1.9 (m, 4H,
OCH2CH(CH3)CH2CH3), 2.00 (m, 6H, OCH2CH2(CH2)9CH3), 3.5 (q,
2H, ArNHCONHCH2), 3.95-4.06 (m, 14H, OCH2), 5.46 (br, 1H,
ArNHH), 6.75 (s, 2H, ArH), 7.03 (d, J ) 16.4 Hz, 1H, ArCHdCHAr),
7.1-7.2 (m, 6H, ArCHdCH, ArH), 7.4 (d, J ) 16.4 Hz, 1H, ArCHd
CH), 7.5-7.6 (m, 4H, ArCHdCH, ArH), 8.22 (s, 1H, ArH), 8.24 (s,
1H, ArH), 9.28 (br, 1H, ArNHCONH), 9.90 (br, 1H, ArNHCONH),
10.24 (br, 1H, ArNHH); 13C NMR (100 MHz, CDCl3) δ 11.58, 11.65,
11.71, 14.00, 14.25, 16.89, 16.95, 16.98, 20.47, 22.81, 26.25, 26.52,
29.47, 29.50, 29.56, 29.75, 29.78, 29.81, 29.82, 29.85, 30.40, 30.47,
31. 79, 32.03, 32.04, 35.11, 35.18, 35.27, 40.01, 69.05, 73.52, 73.94,
74.09, 74.34, 74.38, 77.21, 104.93, 109.26, 109.57, 110.23, 110.61,
122.12, 122.31, 122.66, 125.36, 125.79, 126.128, 126.70, 127.11,
127.18, 128.08, 128.40, 128.49, 133.07, 133.92, 137.95, 141.84, 150.73,
150.87, 150.94, 151.31, 153.03, 155.74, 163.53, 167.74, 169.77; IR
(KBr) υ (cm-1) 1687 (CdO stretch), 3209, 3222, 3301, 3491 (N-H
stretch); IR (CDCl3) υ (cm-1) 3542, 3491, 3424, 3300, 3222, 3209
(hydrogen and non-hydrogen bonded N-H vibrations); MALDI-TOF
MS (MW ) 1490.24) m/z 1489.21 [M]+, 1512.03 [M + Na]+. Anal.
Calcd for C94H148O8N6: C, 72.05; H, 10.26; N, 5.09 Found: C, 72.26;
H, 9.94; N, 5.11.
(E,E,E)-4-[4-{4-(3,4,5-Tridodecyloxystyryl)-2,5-bis[(S)-2-methyl-
butoxy]styryl}-2,5-bis[(S)-2-methylbutoxy]styryl]phenylnitrile (2).
Diethyl(4-cyanobenzyl) phosphonate (0.79 g, 3.10 mmol) was dissolved
in 5 mL of anhydrous DMF and under an argon atmosphere KtBuO
(0.46 g, 4.14 mmol) was added to the solution. After 15 min a solution
of 1 (2.50 g, 2.07 mmol) in 30 mL of DMF/THF (2:1) was added
dropwise to the reaction mixture. The solution was stirred for 72 h
and subsequently poured onto 100 g of crushed ice. HCl (80 mL, 3 N)
was added and the aqueous phase was extracted three times with diethyl
ether. The collected organic fractions were washed with 3 N HCl
solution and dried over MgSO4. After evaporation of the solvent the
product was purified by column chromatography (silica gel, hexane/
CH2Cl2 1:2) to afford 2.47 g (91%) of 2 as a orange solid: 1H NMR
(400 MHz, CDCl3) δ 0.95-1.15 (m, 9H, OCH2CH2(CH2)9CH3, 12H,
OCH2CH(CH3)CH2CH3, 12H, OCH2CH(CH3)CH2CH3), 1.3 (m, 54H,
OCH2CH2(CH2)9CH3), 1.5-1.7 (m, 8H, OCH2CH(CH3)CH2CH3), 1.9
1,6-Bis{2-amino-4-hexadiylureido-6-[(E,E,E)-4- 4-{4-(3,4,5-tris-
dodecyloxystyryl)-2,5-bis[(S)-2-methylbutoxy]styryl}-2,5-bis[(S)-2-